Vaginal dryness is one of the concerns I discuss frequently with women in my practice, yet it remains something many women are hesitant to bring up, even when it begins to affect their comfort, intimacy, and quality of life. I often hear women tell me that they assumed dryness, irritation, or painful intercourse was simply part of getting older, particularly as they approach their forties and fifties, but I want women to understand that these changes are not something they have to accept without exploring the available treatment options.
Estrogen plays an important role in maintaining healthy vaginal tissue by supporting collagen production, elasticity, blood flow, natural lubrication, and the vaginal environment. As estrogen levels fluctuate or decline, the vaginal lining can become thinner, less elastic, and more susceptible to irritation, which can result in dryness, burning, discomfort during intercourse, and sometimes urinary symptoms. Although these changes are particularly common during perimenopause and menopause, I also see them in younger women following childbirth, while breastfeeding, and in women taking certain hormonal contraceptives or medications.
When we discuss hormones, estrogen is usually the first hormone that comes to mind, but maintaining vaginal health involves more than simply looking at one hormone level. Estrogen helps maintain the thickness and elasticity of vaginal tissue, supports natural lubrication, and contributes to an acidic vaginal pH that encourages the growth of beneficial Lactobacillus bacteria. When estrogen declines, these protective mechanisms can change, leaving the vaginal tissue more vulnerable to dryness, irritation, discomfort, and recurrent urinary tract infections.
Testosterone also plays a role in women's sexual health, particularly when we are evaluating changes in libido and sexual function, while thyroid abnormalities and other hormonal changes may contribute to symptoms that affect overall well-being. This is why I prefer to evaluate the complete hormonal picture rather than simply recommend a lubricant or treat vaginal dryness as an isolated problem.
When a woman comes to me with vaginal dryness, I want to understand what else may be happening hormonally, particularly if she is also experiencing changes in her menstrual cycle, reduced libido, sleep disturbances, fatigue, or other symptoms that may suggest changing hormone levels. Depending on her age, menstrual history, symptoms, and medical background, I may consider evaluating estradiol, progesterone, total and free testosterone, SHBG, and thyroid function to help identify other factors that may be contributing to her symptoms.
Estradiol provides information about estrogen levels, although results need to be interpreted in the context of menstrual cycle timing and the stage of reproductive life. Progesterone may be useful when evaluating ovulation and menstrual cycle changes, while total and free testosterone and SHBG can provide additional information when a woman reports changes in sexual desire. Thyroid function is also worth considering because thyroid abnormalities can affect sexual function and overall health.
I do not believe that every woman needs an extensive hormone panel, nor do I believe that a single laboratory result should determine treatment. Hormones fluctuate considerably during perimenopause, and a woman's symptoms, medical history, and physical examination are just as important as her laboratory results. Vaginal dryness itself is a clinical diagnosis and does not require an abnormal blood hormone level before treatment can be considered.
There are several effective approaches to treating vaginal dryness, and the best option depends on the underlying cause, severity of symptoms, medical history, and whether a woman is experiencing other hormonal changes. My goal is to select treatment that addresses the actual needs of the vaginal tissue rather than simply providing temporary relief.
One of the treatments I frequently discuss with patients is local vaginal estrogen, including vaginal estriol preparations. Estrogen supports vaginal tissue thickness, elasticity, collagen production, blood flow, and natural moisture, and when estrogen levels decline, replacing estrogen locally can help improve many of the changes responsible for vaginal dryness and discomfort.
Estriol is a weaker form of estrogen that is used in certain vaginal preparations, including compounded formulations, while FDA-approved vaginal estradiol products are also available in creams, tablets, and rings. These treatments are designed to act primarily on vaginal tissues, although some systemic absorption can occur, and they are different from systemic hormone replacement therapy.
For women experiencing dryness, irritation, and painful intercourse related to declining estrogen, local vaginal estrogen can be particularly helpful because it addresses the underlying tissue changes rather than simply reducing friction during intimacy. Compounded estriol is not FDA-approved, and its dosing and clinical evidence are less standardized than those of approved vaginal estrogen products, so the choice of formulation should be discussed with a physician.
Vaginal DHEA, also known as prasterone, is another option that I discuss with women experiencing vaginal dryness and painful intercourse, particularly when menopause-related changes are affecting the health of their vaginal tissue. DHEA is a hormone precursor that can be converted within tissues into estrogen and androgen hormones, and prescription vaginal prasterone is FDA-approved for moderate to severe painful intercourse associated with menopause-related vaginal changes.
Unlike oral DHEA supplements, vaginal DHEA is administered locally and works within the vaginal tissue to improve tissue health and reduce discomfort. It can be a useful alternative for selected women who are considering options beyond conventional vaginal estrogen, although the choice of treatment should always take into account the patient's medical history and individual needs.
MonaLisa Touch is a fractional CO2 laser treatment developed for vaginal tissue changes and marketed for concerns such as dryness, discomfort during intercourse, and changes in vaginal elasticity. The treatment delivers controlled energy to the vaginal lining with the intention of stimulating tissue remodeling and collagen production, and some women report improvement in their symptoms following treatment.
However, I believe it is important to distinguish between treatments that have established clinical evidence and those that are still being evaluated. Although early studies have reported improvements, larger sham-controlled studies have not consistently demonstrated benefits beyond placebo, and long-term safety and effectiveness remain uncertain. Vaginal laser treatments should therefore not be considered an established replacement for vaginal estrogen or DHEA, and women should understand the limitations of the available evidence before deciding to pursue treatment.
For women with mild symptoms, or those who want additional support alongside hormonal treatment, vaginal moisturizers and lubricants can make a meaningful difference in everyday comfort and sexual activity. Although these products are often discussed together, they serve different purposes, and I want patients to understand how to choose between them.
Vaginal moisturizers are intended for regular use, generally several times a week, to help maintain hydration between sexual activity. Products containing hyaluronic acid or polycarbophil can be helpful for women experiencing persistent dryness, while lubricants are used during intercourse to reduce friction and make intimacy more comfortable.
Water-based lubricants are easy to use and generally compatible with latex condoms, although they may need to be reapplied, while silicone-based lubricants tend to last longer and can be particularly helpful for women with more significant dryness. I generally recommend fragrance-free products without unnecessary additives or ingredients that may irritate sensitive vaginal tissue, and women should discontinue any product that causes burning or discomfort.
It is also important to understand that moisturizers and lubricants provide hydration or reduce friction but do not restore estrogen-depleted vaginal tissue, which is why persistent symptoms deserve a more complete evaluation.
For some women, vaginal dryness is one component of a broader pattern of hormonal changes that may also include hot flashes, night sweats, disrupted sleep, mood changes, reduced libido, and changes in body composition. In these situations, we may discuss systemic hormone therapy as part of a more comprehensive approach to hormonal health, with treatment individualized according to the woman's symptoms, medical history, and risk factors.
Depending on the patient's needs, this may include estrogen and progesterone, and in selected circumstances, testosterone. Systemic hormone therapy and local vaginal treatments serve different purposes, and even women who are already using systemic hormones may continue to experience vaginal dryness that requires additional local treatment. Not every woman with vaginal dryness needs systemic hormone replacement, which is why I believe treatment should be based on a careful evaluation rather than automatically prescribing hormones.
Women who have undergone breast cancer treatment or are taking medications that suppress estrogen can experience particularly significant vaginal dryness, irritation, and painful intercourse. These symptoms can have a substantial effect on quality of life, yet many women are reluctant to discuss them because they are concerned about using any type of hormone treatment.
Nonhormonal moisturizers and lubricants are generally the first approach, but when symptoms persist, selected women may be candidates for low-dose vaginal estrogen or vaginal DHEA following an individualized discussion with their oncologist and gynecologist. The decision requires careful consideration of the cancer history, current medications, and potential benefits and risks of treatment, particularly in women taking aromatase inhibitors.
After more than two decades of caring for women, I have seen how frequently vaginal and hormonal health are overlooked, even though they can have a significant effect on a woman's comfort, relationships, confidence, and overall quality of life. Women are often diligent about their nutrition, exercise, cardiovascular health, and preventive screenings, yet they may tolerate vaginal dryness and discomfort for years because they believe these changes are inevitable or simply do not know that effective treatments are available.
When I evaluate a woman with vaginal dryness, I look at her hormonal history, symptoms, medications, and vaginal tissue health so that we can determine whether local vaginal estrogen, vaginal DHEA, moisturizers, lubricants, or a broader hormonal evaluation would be most appropriate. For some women, local treatment is all that is needed, while others benefit from addressing additional hormonal changes that may be affecting their health.
I believe vaginal health should be part of the larger conversation about women's longevity and healthspan, because maintaining healthy tissue, sexual function, and urinary health is important throughout life, not just during the reproductive years. Women should not have to accept painful intimacy, persistent irritation, or vaginal dryness as an inevitable consequence of aging when there are options available to help them feel comfortable and maintain their quality of life.
